Depression Board decisions

The Board remands the claims for service connection for erectile dysfunction, a left shoulder disability, a right shoulder disability, and a mental health disability due to insufficient evidence.

The Board granted service connection for cervical strain with radiculopathy and denied an evaluation in excess of 50 percent for major depressive disorder with anxious distress.

The Veteran withdrew his appeal for service connection and disability rating, resulting in the dismissal of both claims.

The Board denied the Veteran's appeal for an initial rating in excess of 10 percent for major depressive disorder, finding that his symptoms more closely approximated mild or transient symptoms which decrease work efficiency and ability to perform occupational tasks only during periods of occasional stress.

The Board granted service connection for depressive disorder, secondary to the Veteran's service-connected bilateral spondylolisthesis.

The appeal for service connection for PTSD, depressive disorder, and unspecified anxiety disorder was dismissed due to the untimely filing of the Board Appeal request.

The Board granted service connection for major depressive disorder, resolving all doubt in the Veteran's favor and finding that his condition is related to his active service.

The Board denied service connection for bilateral hearing loss, depression as secondary to left upper extremity peripheral neuropathy and carpal tunnel syndrome, and PTSD. The claims for service connection for left and right upper extremity peripheral neuropathies, a left hand disability, and a right hand disability were remanded.

The Board granted service connection for an acquired psychiatric disorder, to include PTSD, MDD, anxiety disorder and alcohol use disorder. The claim for TDIU prior to November 10, 2021 was denied.

The Board granted an initial rating of 70 percent for the Veteran's alcohol use disorder with an unspecified depressive disorder, finding that his symptoms more nearly approximated occupational and social impairment with deficiencies in most areas.

The Board granted a 70 percent rating for the Veteran's mental health disability from May 17, 2021, to September 20, 2022, but denied a higher rating thereafter.

The Board denied an evaluation in excess of 50 percent for the Veteran's service-connected major depressive disorder and adjustment disorder unspecified, finding that the severity, frequency, and duration of his symptoms did not more closely approximate occupational and social impairment with deficiencies in most areas.

The Board denied a disability rating in excess of 50 percent prior to October 28, 2014, and in excess of 70 percent from October 28, 2014, to September 11, 2019, for the Veteran's major depressive disorder with eating disorder and PTSD.

The Board granted service connection for anxiety condition, insomnia, memory loss, and unspecified depressive disorder. The claims for cervical strain, CFS, ED, fibromyalgia, GERD, hemorrhoids, HTN, IBS, LLE radiculopathy, RLE radiculopathy, LUE radiculopathy, RUE radiculopathy, sinusitis, OSA, and the ratings for allergic rhinitis and migraine headaches were denied.

The Board remands the claims for service connection for an acquired psychiatric disorder, TDIU, and DEA due to a lack of substantial compliance with previous remand directives.

The Board denied service connection for anxiety, depression, headaches, a neck disorder, an upper back disorder, a lower back disorder, and a left arm disorder as there was no evidence of current disabilities during the appeal period.

The appeal for service connection for major depressive disorder (MDD) was dismissed due to the Veteran's death.

The Veteran's service-connected disabilities are as likely as not of such nature and severity as to prevent him from securing or following substantially gainful employment, granting a total disability rating based on individual unemployability (TDIU) on an extraschedular basis.

The Veteran's unspecified depressive disorder is granted as secondary to his service-connected prostate cancer, and a TDIU is granted prior to October 14, 2016.

The Board denied an effective date prior to August 19, 2020, for the grant of eligibility for DEA benefits under 38 U.S.C. Chapter 35.